NC71
NOTICE OF CANCELLATION SEC. 71 E-MAILED
02/10/2026
Back to search
Official data from USPTO
OPTHEA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
35
Latest update
03/03/2026
Trademark type
Word
Nice classes
5, 42
Filing date
12/07/2016
Registration date
05/29/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/10/2026
Last transaction
03/03/2026
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
4
Owner type
03
Owner location
SOUTH YARRA VIC, AU
Examiner
THOMAS, JULIE
Current location
Historical data usage
Holders and representatives
Holders
Opthea Limited
Opthea Limited
Representatives
Richard M. LaBarge Marshall, Gerstein & Borun LLP
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Biological preparations for pharmaceutical purposes for the treatment of ophthalmic conditions; Chemical preparations for pharmaceutical purposes for the treatment of ophthalmic conditions; Chemical productssugarsproteins and nucleic acids for pharmaceutical use for the treatment of ophthalmic conditions; Chemicals for pharmaceutical use for the treatment of ophthalmic conditions; Pharmaceutical compositions for the treatment of ophthalmic conditions; Pharmaceutical creams for the treatment of ophthalmic conditions; Pharmaceutical drugs for the treatment of ophthalmic conditions; Pharmaceutical preparations for the treatment of ophthalmic conditions ; Pharmaceutical preparations for animals for the treatment of ophthalmic conditions; Pharmaceutical preparations for human use for the treatment of ophthalmic conditions; Pharmaceutical preparations for personal use for the treatment of ophthalmic conditions; Pharmaceutical preparations for veterinary use for the treatment of ophthalmic conditions; Pharmaceutical products for the treatment of ophthalmic conditions; Pharmaceutical products for use by humans for the treatment of ophthalmic conditions; Pharmaceutical substances for the treatment of ophthalmic conditions; Veterinary medicaments for the treatment of ophthalmic conditions; Veterinary preparations for the treatment of ophthalmic conditions; Veterinary products for the treatment of ophthalmic conditions; Biological preparations for medical purposes for the treatment of ophthalmic conditions; Biological preparations for use in biotechnology for the treatment of ophthalmic conditions; Biological preparations for use in cell culturesnamely in culture media for cultivating humananimalplant or microorganism cells for medical use; Biological preparations for veterinary purposes for the treatment of ophthalmic conditions; Biological products for medical usenamely for the treatment of ophthalmic conditions; Biological reagents for use in molecular biology for medical use; Biological substances for medical usebiologicsantibodiesmonoclonal antibodiescells and cellular tissues for medical usenamely for the treatment of ophthalmic conditions; Biological tissue cultures for medical purposes; Biological tissue cultures for veterinary purposes; Chemical productsbiologicssugarsproteinsnucleic acids and pharmaceuticals for use in biology for medical or veterinary usenamely for the diagnosis of ophthalmic conditionsorfor the treatment of ophthalmic conditions; Therapeutic biological productsbiologicsantibodiesmonoclonal antibodiescells and cellular tissues for medical usenamely for the treatment of ophthalmic conditions; Medical preparations for the treatment of ophthalmic conditions; Substances for use in genetic probe assay kits for medical usemedical diagnostic reagents and assays for testing body fluids; Substances for veterinary use produced by genetic engineeringgenetically engineered tissues for transplant purposes; Cultures of cell media for medical use; Cultures of cell media for veterinary purposes; Chemical products for medical or veterinary laboratory usebiologicssugarsproteinsnucleic acids and pharmaceuticals for the diagnosis of ophthalmic conditionsorfor the treatment of ophthalmic conditions; Chemical preparations for medical analysis purposesbiologicssugarsproteinsnucleic acids and pharmaceuticals for the diagnosis of ophthalmic conditions; Chemical preparations for medical purposes for the diagnosis of ophthalmic conditionsorfor the treatment of ophthalmic conditions; Chemical preparations for veterinary purposesbiologicssugarsproteinsnucleic acids and pharmaceuticals for the diagnosis of ophthalmic conditionsorfor the treatment of ophthalmic conditions; Chemical products for analysis for medical purposesbiologicssugarsproteinsnucleic acids and pharmaceuticals for the diagnosis of ophthalmic conditions; Chemical products for analysis for veterinary purposesbiologicssugarsproteinsnucleic acids and pharmaceuticals for the diagnosis of ophthalmic conditions; Chemical products for biotechnological purposes for medical usesbiologicssugarsproteinsnucleic acids and pharmaceuticals for the diagnosis of ophthalmic conditionsorfor the treatment of ophthalmic conditions; Chemical products for biotechnological purposes for veterinary usebiologicssugarsproteinsnucleic acids and pharmaceuticals for the diagnosis of ophthalmic conditionsorfor the treatment of ophthalmic conditions; Chemical products for medical or veterinary diagnostic purposesbiologicssugarsproteinsnucleic acids and pharmaceuticals for the diagnosis of ophthalmic conditions; Chemical products for medical diagnostic usebiologicssugarsproteinsnucleic acids and pharmaceuticals for the diagnosis of ophthalmic conditions; Chemical products for veterinary diagnostic usebiologicssugarsproteinsnucleic acids and pharmaceuticals for the diagnosis of ophthalmic conditions; Chemical products for medical usebiologicssugarsproteinsnucleic acids and pharmaceuticals for the diagnosis of ophthalmic conditionsorfor the treatment of ophthalmic conditions; Chemical products for use in medical sciencebiologicssugarsproteinsnucleic acids and pharmaceuticals for the diagnosis of ophthalmic conditionsorfor the treatment of ophthalmic conditions; Chemical products for use in science for medical or veterinary purposesbiologicssugarsproteinsnucleic acids and pharmaceuticals for the diagnosis of ophthalmic conditionsorfor the treatment of ophthalmic conditions; Chemicals for use in medical and veterinary analysisbiologicssugarsproteinsnucleic acids and pharmaceuticals for the diagnosis of ophthalmic conditions
Class 42
Advisory services relating to scientific research; Laboratory servicesscientific research or analysis in the field of ophthalmology; Management of scientific research projects; Medical research and scientific research for medical purposes; Preparation of reports relating to scientific research; Preparation of scientific reports; Providing informationincluding onlineabout scientific and technological services and research and design relating theretonamely for scientific researchanalyses and testing in the field of ophthalmology; Provision of information relating to scientific research; Provision of scientific information in the field of ophthalmology; Scientific advisory services in the field of ophthalmology; Scientific analysis in the field of ophthalmology; Technical analysis for research and testing in the field of ophthalmology; Scientific and technological services namely for scientific researchanalysis and testing in the field of ophthalmology; Scientific consultancy relating to ophthalmic conditions; Scientific laboratory services; Scientific research; Scientific research in the field of pharmacy; Scientific research into the development of new products; Scientific research relating to bacteriology; Scientific research relating to biology; Scientific research relating to chemical products; Scientific research relating to chemistry; Scientific research relating to genetics; Scientific testing services in the field of ophthalmology; Bacteriological research; Biochemistry research services; Biological research; Biotechnological research; Biotechnology research; Chemical research; Chemical technological research; Genetic research; Laboratory research; Medical research; Pharmaceutical research services; Providing informationincluding onlineabout industrial analysis and research services namely for scientific researchanalyses and testing in the field of ophthalmology; Provision of medicalveterinarybiological and pharmaceutical research services in the field of ophthalmology; Research and development of new products for others; Research and development of products; Research into the development of new products; Research laboratories in the field of ophthalmology; Research relating to bacteriology; Research relating to biotechnology; Research relating to chemicals; Research relating to chemistry; Research relating to medicine; Research relating to molecular sciences; Research relating to pharmaceuticals; Research relating to science; Research to develop new products; Services for assessing the efficiency of pharmaceuticals namely pharmaceutical product evaluation; Services for assessing the safety of pharmaceuticalsnamely testinginspection or research of pharmaceuticals; Chemical analysis; Laboratory analysis in the field of ophthalmology; Analysis of tissues for medical research; Design of medical apparatus; Medical laboratory services; Analytical laboratory servicesnamely analysis of tissue samples or bodily fluids for diagnostic purposes; Chemical laboratory services; Laboratory testing servicesnamely testing of tissue samples or bodily fluids for diagnostic purposes; Veterinary laboratory services; Information in the field of chemical research; Testing of chemicals
Publications
History of USPTO decisions and trademark events.
35 publications found
C71T
CANCELLED SECTION 71
02/10/2026
PR71
POST REGISTRATION ACTION MAILED - SEC.71
07/28/2025
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
07/07/2025
PR71
POST REGISTRATION ACTION MAILED - SEC.71
01/04/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/26/2024
ES71
TEAS SECTION 71 RECEIVED
05/22/2024
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
05/29/2023
LIMN
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
12/15/2022
RHRD
RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED
12/03/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
01/02/2021
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
09/28/2018
FICS
FINAL DISPOSITION NOTICE SENT TO IB
09/12/2018
FIMP
FINAL DISPOSITION PROCESSED
09/12/2018
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
08/29/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
05/29/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/13/2018
PUBO
PUBLISHED FOR OPPOSITION
03/13/2018
GPNX
NOTIFICATION PROCESSED BY IB
03/09/2018
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
02/21/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/21/2018
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
02/21/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/06/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/09/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/08/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/08/2018
RFNT
REFUSAL PROCESSED BY IB
07/28/2017
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
07/06/2017
RFRR
REFUSAL PROCESSED BY MPU
07/06/2017
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
06/30/2017
CNRT
NON-FINAL ACTION WRITTEN
06/29/2017
MAFR
APPLICATION FILING RECEIPT MAILED
06/27/2017
DOCK
ASSIGNED TO EXAMINER
06/23/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/23/2017
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
06/22/2017
Continuous trademark protection
Get notified about every new filing that threatens OPTHEA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.